Sharda Cropchem
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Sharda Cropchem's management has expressed confidence in the company's asset-light, IP-led business model, which has successfully navigated recent global challenges. The focus on expanding its extensive registration portfolio, with over 3,000 registrations and a pipeline of 1,004 pending applications, positions the company well for sustained revenue growth. Management projects a revenue increase of 10-15% for FY27, supported by a recovering agrochemical market and improved pricing power. Despite facing margin pressures due to raw material costs and geopolitical risks, the company maintains a strong balance sheet and a commitment to financial discipline. Vista's forecast aligns with these developments, anticipating stable margins around 18-20% EBITDA and an attractive valuation with a 35% expected upside. The favorable macro environment, characterized by government support for agriculture and improving demand, further bolsters the outlook. Key opportunities include expanding market share in North America and Latin America, while watchpoints include potential currency volatility and regulatory delays in product registrations. Overall, Sharda Cropchem is well-positioned for growth, albeit with some inherent risks that need monitoring
Why We Like This Stock
- Strong revenue growth projected at 10-15% for FY27, supported by a recovering agrochemical market
- A significant pipeline of 1,004 pending registrations enhances future product launches and market entries
- Debt-free balance sheet and strong cash position provide a solid foundation for long-term growth
Things To Watch Out For
- Margin pressures from rising raw material costs and geopolitical risks could impact profitability
- Potential delays in regulatory approvals for product registrations may hinder growth momentum
- Currency volatility poses risks to earnings, particularly in international markets
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 3,163 | 4,320 | 5,268 | 5,182 | 5,571 |
| Profit Before Tax (Cr.) | 72 | 371 | 856 | 777 | 886 |
| PBT Margin | 2.3% | 8.6% | 16.2% | 15.0% | 15.9% |
| Net Profit (Cr.) | 43 | 319 | 708 | 646 | 737 |
| Earnings Per Share | 4.8 | 35.4 | 78.5 | 71.7 | 81.7 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Anand Rathi | ▲ Buy | 1,350 | 31-Jul-2026 |
| Khambatta Securities | ▲ Buy | 1,325 | 18-May-2026 |
Company Overview
Show Company Profile
Sharda Cropchem Limited, a crop protection chemical company, engages in the provision of various formulations and generic active ingredients worldwide. The company operates through Agrochemicals and Non- Agrochemicals segments. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth regulators, fumigants, regulators, rodenticides, dithianon, metalaxyl, propiconazole, phenthoate, pendimethalin, and dithianon; and biocides. The company also provides conveyor belts, such as textile ply, rough top, steel cord, chevron/pattern, elevator, sidewall, pipe, and PVC/PVG solid woven conveyor belts, as well as cotton transmission belts, PVC and polyurethane light duty belting products, and V-belts. In addition, it offers industrial chemicals used in water treatment, food and food ingredients, and other industrial applications; and dyes and dye intermediates, as well as general chemicals. Further, the company supplies and distributes pharmaceuticals and intermediates products, including prothioconazole, azoxystrobin, P-nitrophenol - parathion-methyl, 2,4-dichloroacetophenone - propiconazole, cyclopropanecarboxylic acid - trinexapac-ethyl, and P-fluorobenzaledehyde - cyfluthrin. Sharda Cropchem Limited was founded in 1987 and is based in Mumbai, India.